Drug Giants’ Rebate Plan Could Gut Rural Hospitals
2 Articles
2 Articles
Drug Giants’ Rebate Plan Could Gut Rural Hospitals
A change to a federal drug discount policy that provides lower-cost prescription medications to clinics and hospitals serving low-income and other disadvantaged communities could bankrupt rural hospitals, a new study finds. The report, from 340B Health, claims that changes proposed by major drugmakers to replace upfront discounts with post-sale rebates for some or all outpatient drugs would hit safety-net hospitals with significant additional co…
340B Health Survey: Most Hospitals Would Struggle to Stay Open, Maintain Care Levels Under 340B Rebate Model - 340B Report
A majority of 340B hospitals surveyed said the costs associated with implementing drugmakers’ proposed rebate models would hinder their ability to keep their doors open—with over a quarter anticipating potential layoffs if they have to wait even just one month for drugmaker rebates, a recent 340B Health analysis found.
Coverage Details
Bias Distribution
- 100% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium